These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 15451836)

  • 21. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
    Balla I; Petrela E; Kondili A
    Anadolu Kardiyol Derg; 2011 Nov; 11(7):600-6. PubMed ID: 21911317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.
    Kim MH; Smith PJ; Jhaveri M; Lin J; Klingman D
    Clin Ther; 2011 Nov; 33(11):1668-1681.e1. PubMed ID: 22108302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM
    Card Electrophysiol Rev; 2003 Sep; 7(3):201-7. PubMed ID: 14739713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation.
    Bandini A; Golia P; Pantoli D; Galvani M; Rusticali F
    Ital Heart J; 2005 Jul; 6(7):584-90. PubMed ID: 16274021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs].
    Viñolas X; Freire F; Romero-Menor C; Alegret JM
    Med Clin (Barc); 2013 Apr; 140(8):351-5. PubMed ID: 22982132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost evaluation of rhythm control methods for atrial fibrillation: evidence from CTAF.
    Nattel S; Lumer G; Talajic M; Roy D
    Card Electrophysiol Rev; 2003 Sep; 7(3):211-4. PubMed ID: 14739715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.
    Deneer VH; Borgh MB; Kingma JH; Lie-A-Huen L; Brouwers JR
    Pharm World Sci; 2004 Apr; 26(2):66-78. PubMed ID: 15085940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
    Mooss AN; Wurdeman RL; Sugimoto JT; Packard KA; Hilleman DE; Lenz TL; Rovang KS; Arcidi JM; Mohiuddin SM
    Am Heart J; 2004 Oct; 148(4):641-8. PubMed ID: 15459595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
    Schilling RJ
    Heart; 2010 Mar; 96(5):333-8. PubMed ID: 19910286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic drugs in the management of atrial fibrillation.
    Cowan JC
    Br Heart J; 1993 Oct; 70(4):304-6. PubMed ID: 8217437
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antiarrhythmic drugs in atrial fibrillation].
    Brembilla-Perrot B
    Rev Prat; 2002 Jun; 52(12):1317-23. PubMed ID: 12187895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
    Alboni P; Botto GL; Baldi N; Luzi M; Russo V; Gianfranchi L; Marchi P; Calzolari M; Solano A; Baroffio R; Gaggioli G
    N Engl J Med; 2004 Dec; 351(23):2384-91. PubMed ID: 15575054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
    Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of an electropharmacological transesophageal test in the prevention of paroxysmal atrial fibrillation. Experience with flecainide].
    De Sisti A; Matteucci C; Patrissi T; Accogli S; Di Lorenzo M; Sasdelli M; Ciolli A; Lo Sardo G; Palamara A
    G Ital Cardiol; 1998 Dec; 28(12):1391-9. PubMed ID: 9887393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.